Abiopharma

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

FONAR SIGNS DEFINITIVE AGREEMENT

Breyting á fjölda eigin hluta

Changes in companys own shares

Changes in companys own shares

Shareholder Alert: The Ademi Firm investigates whether DigitalBridge Group, Inc. is obtaining a Fair Price for its Public Shareholders

IMUNON 2025, A TRANSFORMATIVE YEAR OF SIGNIFICANT CLINICAL ADVANCES, LOOKING AHEAD TO 2026

UTHR: Notification